A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.
To understand the hidden dimensions of COPD among non-smokers, The Week spoke with pulmonologist Dr Shahid Patel, consultant ...
Fragranced consumer products emit volatile organic compounds that form nanoparticles, contributing to indoor air pollution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback